Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

AppLovin Shares Jump as Revenue Continues to Surge. Is It Too Late to Buy the Stock?
AppLovin Shares Jump as Revenue Continues to Surge. Is It Too Late to Buy the Stock?

AppLovin (NASDAQ: APP) once again held up to the short-seller scrutiny it's been under, with yet another quarter of surging revenue and profitability growth. The stock is now up more than 500% over

Parks America Posts Q3 Profit Surge
Parks America Posts Q3 Profit Surge

Parks! America (OTC:PRKA), an operator of three regional safari parks in Georgia, Missouri, and Texas, reported earnings for its fiscal third quarter on August 8, 2025, with income before income

Why Is Everyone Talking About UnitedHealth Group Stock?
Why Is Everyone Talking About UnitedHealth Group Stock?

UnitedHealth (NYSE: UNH) stock is trading near its 52-week low.

*Stock prices used were the afternoon prices of Aug. 4, 2025. The video was published on Aug. 6, 2025.

Continue reading

Source Fool.c

MicroVision (MVIS) Q2 Revenue Drops 92%
MicroVision (MVIS) Q2 Revenue Drops 92%

MicroVision (NASDAQ:MVIS), a company specializing in lidar (light detection and ranging) sensor hardware and integrated perception software for automotive, industrial, and defense markets, reported

Natera (NTRA) Q2 Revenue Jumps 32%
Natera (NTRA) Q2 Revenue Jumps 32%

Natera (NASDAQ:NTRA), a leader in genetic testing across oncology, women's health, and organ health, reported its earnings for Q2 2025 on August 7, 2025. The most significant news was a 32.2%

Trupanion (TRUP) Q2 Profit Surges 124%
Trupanion (TRUP) Q2 Profit Surges 124%

Trupanion (NASDAQ:TRUP), a provider of pet health insurance, reported results for the second quarter of fiscal 2025 on August 7, 2025. The company surprised analysts with diluted earnings per share

SCPH Revenue Up 99%
SCPH Revenue Up 99%

scPharmaceuticals (NASDAQ:SCPH), a commercial-stage pharmaceutical company focused on subcutaneous drug delivery for heart failure and chronic kidney disease patients, delivered its second quarter

Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (PODD) Q2 Revenue Jumps 33%

Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong

EQS-News: RHÖN-KLINIKUM AG closes first half of 2025 with solid results
EQS-News: RHÖN-KLINIKUM AG closes first half of 2025 with solid results
EQS-News: RHÖN-KLINIKUM AG closes first half of 2025 with solid results
EQS-News: Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
EQS-News: Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
EQS-News: Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
If You'd Invested $1,000 in UnitedHealth Group 3 Years Ago, Here's How Much You'd Have Today
If You'd Invested $1,000 in UnitedHealth Group 3 Years Ago, Here's How Much You'd Have Today

UnitedHealth Group (NYSE: UNH) has been in the news over the past several months, but not positively. Unfortunately, the CEO of its healthcare unit, Brian Thompson, was shot and killed late last

UnitedHealth Stock Investors: You Need to Know This Before Buying or Selling This Stock
UnitedHealth Stock Investors: You Need to Know This Before Buying or Selling This Stock

UnitedHealth Group (NYSE: UNH) stock investors will want to digest this information before making the important decision to invest in or divest from this stock.

*Stock prices used were the

LeMaitre (LMAT) Q2 Revenue Jumps 15%
LeMaitre (LMAT) Q2 Revenue Jumps 15%

LeMaitre Vascular (NASDAQ:LMAT), a medical device company focused on vascular surgeons, reported its latest quarterly earnings after the bell on August 5, 2025. The company delivered GAAP results

QuidelOrtho (QDEL) Fiscal Q2 EPS Beats
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats

QuidelOrtho (NASDAQ:QDEL), a global provider of diagnostic testing solutions, released its financial results for the quarter ended June 29, 2025, on August 5, 2025. The most notable headline was a

OCUL Sales Drop 18%
OCUL Sales Drop 18%

Ocular Therapeutix (NASDAQ:OCUL), a biotechnology company developing therapies for eye diseases, reported its second quarter results on August 5, 2025. The earnings release pointed to a significant

Columbia Bank (COLB) Earnings Call Transcript
Columbia Bank (COLB) Earnings Call Transcript

Image source: The Motley Fool.

Need a quote from a Motley Fool analyst? Email [email protected]

Columbia Banking System(NASDAQ:COLB) delivered operating results for fiscal Q2 2025 reflecting a 14%

UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?
UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?

Things are going from bad to worse for UnitedHealth Group (NYSE: UNH). Investors were already enduring a tough year in 2025, with the company facing myriad bits of bad news, including poor financial

Southern Company Boosts Capital Plan
Southern Company Boosts Capital Plan

Southern Company (NYSE:SO) reported its second quarter 2025 earnings on July 31, 2025, announcing a $13 billion increase in its five-year base capital plan to $76 billion. The company highlighted

HealthStream (HSTM) Q2 Revenue Up 4%
HealthStream (HSTM) Q2 Revenue Up 4%

HealthStream (NASDAQ:HSTM), a leading provider of healthcare workforce and training solutions, reported its results on August 4, 2025, for the fiscal second quarter ended June 30, 2025. The most

EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-Adhoc: Gerresheimer AG to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
If You'd Invested $1,000 in Medtronic (MDT) Stock 5 Years Ago, Here's How Much You'd Have Today
If You'd Invested $1,000 in Medtronic (MDT) Stock 5 Years Ago, Here's How Much You'd Have Today

What were you doing five years ago? Were you working from home due to the new pandemic? Watching Shakira and J. Lo perform at the Super Bowl? Perhaps you were buying some stocks. If you spent $1,000

Waters (WAT) Q2 Revenue Jumps 9%
Waters (WAT) Q2 Revenue Jumps 9%

Waters (NYSE:WAT), the analytical instruments and laboratory technology leader, released its Q2 2025 earnings on August 4, 2025. The company's results topped Wall Street estimates, reporting revenue

3 Dividend Stocks to Double Up on Right Now
3 Dividend Stocks to Double Up on Right Now

If you are looking to buy some dividend stocks right now, you'll want to get to know Realty Income (NYSE: O), PepsiCo (NASDAQ: PEP), and Medtronic (NYSE: MDT). All three are reliable dividend payers

3 Reasons to Buy Medtronic Stock
3 Reasons to Buy Medtronic Stock

Medical device specialist Medtronic (NYSE: MDT) has not been the best of investments over the past five years. The stock has significantly lagged the market over this period, thanks to weak business